DYAMTWVR* – SIL Dupilumab signature peptide qualifier

DYAMTWVR Stable Isotope Labeled Infliximab (DPL) peptide serves as a secondary internal standard to confirm DPL’s presence in biological samples by mass spectrometry.

SB-PEPTIDE’s Dupilumab SIL signature peptide qualifier is designed and optimized to provide the best mass spectrometry performance during your Mass Spec assay. It is used in combination with Dupilumab SIL peptide quantifier, that is used as primary internal standard for DPL detection and quantification.

Technical specification

APYTFGQGTK - SIL buy Sequence : DYAMTWV-R*-  [R*= R(13C/15N)]
APYTFGQGTK - SIL synthesis MW : 1 051.11 Da (C47H68N12O13S)
APYTFGQGTK - SIL standard price Purity : > 95%
APYTFGQGTK - SIL peptide standard synthesis Counter-Ion : TFA Salts (see option TFA removal)
Peptide library synthesis abeta peptide Delivery format : Freeze dried in propylene 2mL microtubes
buy synthesized peptide standard Other name : SIL DPL signature peptide qualifier
APYTFGQGTK - SIL standard solubility guidelines Peptide Solubility Guideline
buy peptide price Bulk peptide quantities available


Catalog code Size Price € Price $ USD
SB295-0.1MG 0.1 mg 385 481